Feed aggregator

Syndicate content

New leak of TPP consolidated text on intellectual property provides details of pandering to drug companies and publishers

Knowledge Ecology International - Thu, 16/10/2014 - 11:03

For more information:
James Love, Knowledge Ecology International
email: james.love@keionline.org, +1.202.361.3040

The May 16, 2014 version of the consolidated negotiating text for the Intellectual Property Chapter for the Trans-Pacific Partnership (TPP) agreement is a long, complex document that taken as a whole is designed to expand and extend monopolies on knowledge goods, including in particular publisher-owned copyrights, patents on inventions, and monopoly rights in data used to register new drugs, vaccines and agricultural chemical products.

read more

Categories: Front page

“Can we afford our medicines?” November 12th event.

Trans Atlantic Consumer Dialogue - Mon, 13/10/2014 - 14:46

‘’Can we afford our medicines?
The access to medicines crunch in Europe”

European Parliament (room A3G-3), 12 November 2014, 12:30-15:00

We would like to invite you to the conference “Can we afford our medicines? The access to medicines crunch in Europe” under the auspices of MEPsNessa CHILDERS (S&D, IE), Beatriz BECERRA BASTERRECHEA (ALDE, ES), Kostas CHRYSOGONOS (GUE/NGL, EL), Michèle RIVASI (Greens/EFA, FR) with the support of the TransAtlantic Consumer Dialogue (TACD), Salud por Derecho, Health Action International (HAI) Europe, Doctors of the World – Médecins du monde International Network, Universities Allied for Essential Medicines (UAEM).

Health is a fundamental universal right and access to medicines is part of it. The EU and its Member states are committed to universal and equitable access to healthcare. Nevertheless, millions of European patients suffer from the lack of affordability of many life-saving medicines across Europe. The debate will examine the status quo regarding access to medicines in Europe and explore policy recommendations for more affordable medicines. Possible solutions to be considered will be: new forms of pooled procurement, price and data transparency, cost-therapeutic benefit assessment of medical products and greater generic competition. We shall also debate new biomedical R&D strategies that increase the social return of public investments and promote affordable health-driven innovation which “de-links” research costs from final medicine prices.

Programme (12:30-15:00, room A3G-3)

 

Welcoming remarks by sponsoring MEPs

 

Affordable access to medicines: the situation on the ground

Moderated by Jamie Love @jamie_love, Director, Knowledge Ecology International (KEI) & U.S. Chair of the Intellectual Property Committee, TACD 

 

  • Chloé Forette @Chloe_MdM, Harm Reduction Advocacy Officer, Médecins du Monde @MdM_France
  • Gonzalo Fanjul @GonzaloFanjul, Policy Director, IS Global Barcelona Institute for Global Health @ISGlobalorg
  • Rohit Malpani @MSF_access, Director, Access Campaign, Médecins Sans Frontières (MSF)

 

Q&A session

 

What can we do about the high cost of medicines?

Moderated by Ellen ‘t Hoen @ellenthoen, Medicines Law & Policy.

 

  • Teresa Alves, International Policy Adviser, La Revue Prescrire,
  • Prof. dr. Graham Dukes, University of Oslo
  • Prof. dr. Huub Schellekens, University of Utrecht

 

Q&A session

Concluding remarks by sponsoring MEPs

The European Commission will be represented by DG Enterprise & DG SANCO.

Please join the discussion on twitter using #a2mEurope. Also note that the event will be webstreamed live (more information to follow).

We would kindly ask you to register your attendance (please mention title & organisation represented) to a2m.europe@gmail.com by Thursday 6 November 2014. Should you require a badge to access the European Parliament, please do not forget to provide us with your full name, nationality, passport/ID number and date of birth.

 

A light lunch will be served at the start of the event.

Categories: Front page

European Parliament event: “Can we afford our medicines?” November 12th

Trans Atlantic Consumer Dialogue - Thu, 09/10/2014 - 13:58

‘’Can we afford our medicines?
The access to medicines crunch in Europe”

European Parliament (room A3G-3), 12 November 2014, 12:30-15:00

We would like to invite you to the conference “Can we afford our medicines? The access to medicines crunch in Europe” under the auspices of MEPsNessa CHILDERS (S&D, IE), Beatriz BECERRA BASTERRECHEA (ALDE, ES), Kostas CHRYSOGONOS (GUE/NGL, EL), Michèle RIVASI (Greens/EFA, FR) with the support of the TransAtlantic Consumer Dialogue (TACD), Salud por Derecho, Health Action International (HAI) Europe, Doctors of the World – Médecins du monde International Network, Universities Allied for Essential Medicines (UAEM).

Health is a fundamental universal right and access to medicines is part of it. The EU and its Member states are committed to universal and equitable access to healthcare. Nevertheless, millions of European patients suffer from the lack of affordability of many life-saving medicines across Europe. The debate will examine the status quo regarding access to medicines in Europe and explore policy recommendations for more affordable medicines. Possible solutions to be considered will be: new forms of pooled procurement, price and data transparency, cost-therapeutic benefit assessment of medical products and greater generic competition. We shall also debate new biomedical R&D strategies that increase the social return of public investments and promote affordable health-driven innovation which “de-links” research costs from final medicine prices.

Programme (12:30-15:00, room A3G-3)

 

Welcoming remarks by sponsoring MEPs

 

Affordable access to medicines: the situation on the ground

Moderated by Jamie Love @jamie_love, Director, Knowledge Ecology International (KEI) & U.S. Chair of the Intellectual Property Committee, TACD 

 

  • Chloé Forette @Chloe_MdM, Harm Reduction Advocacy Officer, Médecins du Monde @MdM_France
  • Gonzalo Fanjul @GonzaloFanjul, Policy Director, IS Global Barcelona Institute for Global Health @ISGlobalorg
  • Rohit Malpani @MSF_access, Director, Access Campaign, Médecins Sans Frontières (MSF)

 

Q&A session

 

What can we do about the high cost of medicines?

Moderated by Ellen ‘t Hoen @ellenthoen, Medicines Law & Policy.

 

  • Teresa Alves, International Policy Adviser, La Revue Prescrire,
  • Prof. dr. Graham Dukes, University of Oslo
  • Prof. dr. Huub Schellekens, University of Utrecht

 

Q&A session

Concluding remarks by sponsoring MEPs

The European Commission will be represented by DG Enterprise & DG SANCO.

Please join the discussion on twitter using #a2mEurope. Also note that the event will be webstreamed live (more information to follow).

We would kindly ask you to register your attendance (please mention title & organisation represented) to a2m.europe@gmail.com by Thursday 6 November 2014. Should you require a badge to access the European Parliament, please do not forget to provide us with your full name, nationality, passport/ID number and date of birth.

 

A light lunch will be served at the start of the event.

Categories: Front page

UPDATE: TRIPS Council (Oct. 2014): Ukraine requests discussion on compatibility of tobacco plain packaging measures with TRIPS

Knowledge Ecology International - Mon, 06/10/2014 - 06:05

UPDATE: On 17 October 2014, the Secretariat of the World Trade Organization (WTO) circulated an updated WTO airgram WTO/AIR/4358 REV. 1 to its Members following a request by Ukraine. Ukraine requested the addition of an item on "Concerns with Respect to Measures Related to Plain Packaging of Tobacco Products and their Compatibility with the TRIPS Agreement." This will be discussed under agenda item 13.

read more

Categories: Front page

What PhRMA Wants from TTIP

Knowledge Ecology International - Thu, 02/10/2014 - 19:23


From the TTIP Stakeholder Forum.

Categories: Front page

KEI Notes & Comments at TTIP Seventh Round of Negotiations at Stakeholder Event

Knowledge Ecology International - Thu, 02/10/2014 - 16:42

The 7th Round of the negotiations of the Transatlantic Trade and Investment Partnership (TTIP) Agreement began Monday September 29, 2014 in the United States. This round's paltry effort at transparency, the TTIP Stakeholder Engagement Day, was held at the suburban 4-H conference center in Chevy Chase, MD. Although the information packet for the event included public transport instructions, the location was difficult to access for any attendees without a car, and even then, parking was extremely limited.

read more

Categories: Front page

Matrix of Export Possibilities under Gilead HCV Licence

Knowledge Ecology International - Thu, 02/10/2014 - 09:53

KEI was asked to make a presentation on Hepatitis C, on September 30, 2014, at a lunch seminar at UNITAID. I am attaching a PDF of the slides I used, as well as an eight page memo that takes a look at the recent Gilead license. The memo on the license was last edited on September 30, 2014, and is presented as a draft that may be revised in the future.

read more

Categories: Front page

Notes on new EC Commissioners about access to knowledge

Trans Atlantic Consumer Dialogue - Wed, 01/10/2014 - 10:20

Notes on access to knowledge and IPR challenges of the new European Commission

 

 

Carlos Moedas, Commissioner for Research, Science and Innovation

 

It is generally accepted that copyright constitutes a barrier for EU researchers and weakens their ability to access published research results. The new commissioner, though it is not his direct competence, will probably support a EU copyright reform that includes some kind of EU-wide copyright exception for scientific researchers.

 

The new Research Commissioner will also have to deal with the application, very partial to date, of the EU´s new mandatory policy of open access to EC funded scientific published research results and the promotion of open data policies to become the norm by 2020. This also includes an alignment of EU member states open access policies through the European Research Area.

 

It will also be interesting to see how Moedas uses the mechanism of innovation inducement prizes in the area of biomedical research of Horizon 2020 after a few pilot projects have been launched.

 

The transparency, IPR rules and social return of the public-private partnership Innovative Medicines Inititative, particulary concerning antibiotic resistance, is also important to follow. The EU´s positions on the WHO process on new models of R and D for medicines will also be important to monitor.

 

Gunther Oettinger, Commissioner for Digital Economy and Society

 

Oettinger has committed himself to presenting an EU copyright reform proposal within a year. It is important to note that the competence over EU copyright has moved from the DG Internal Market to DG Connect that will be headed by Oettinger. The copyright unit headed by Maria Martín Prat will now move under a more copyright reform regime. The big challenge will be to try to overcome very different national copyright and licensing rules to conform a single digital market. Harmonizing exceptions and limitation to copyright, including exceptions for Text and Data mining as well as for libraries, might be some of the issues.

 

The regulation of cloud computing, big data and data protection will also be big challenges that will partially be considered with the context of the TTIP negotiations and trans-Atlantic business parctices.

 

It will be interesting to follow if the new Commissioner mandates any changes in EU strategy at WIPO on both the proposed broadcasting treaty and exceptions to copyright for libraries. To date the EU has been radically opposed to copyright reform for libraries at WIPO, to the point of blocking any progress at the UN institution. Another important issue will be the pending EU ratification of the Marrakesh Treaty for visually impaired persons that is blocked due to procedural issues over EU/member state competences.

 

 

Vytenis Andriukaitis, Commissioner for Health and Food Safety

 

While competence over pharmaceuticals, including the European Medicines Agency, has been moved to the Industry DG, the new Health Commissioner has insisted that he would make joint proposals with the Industry Commissioner and that his opinions would carry equal weight.

He has suggested coordinating among EU member states to lower the high price of life-saving medicines, possibly through pooled procurement. No mention of IPR was made during his hearing.

He was adamant about supporting transparency and preventing conflict of interests.

 

 

 

Categories: Front page

WIPO General Assembly: Worst ever?

Knowledge Ecology International - Tue, 30/09/2014 - 21:47
Brazil asks delegates to embrace work on copyright exceptions

read more

Categories: Front page

WIPO General Assembly 2014, 30 September 2014: Brazilian proposal on SCCR

Knowledge Ecology International - Tue, 30/09/2014 - 21:46

During intense plenary discussions regarding WIPO's future work program on the protection of broadcasting organizations and copyright limitations and exceptions, Brazil made the following proposal to reproduce language from the General Assembly decision of 2013. Brazil proposed,

read more

Categories: Front page

WIPO General Assembly 2014: Decision Paragraph on the Design Law Treaty-Decision punted till 2015

Knowledge Ecology International - Tue, 30/09/2014 - 18:18

On 30 September 2014, the WIPO secretariat handed the following text relating to the "Consideration of the Convening of a Diplomatic Conference for the Adoption of a Design Law Treaty (DLT)."

Consideration of the Convening of a Diplomatic Conference for the Adoption of a Design Law Treaty (DLT)

Agenda item 14 Decision Paragraph

The WIPO General Assembly:

Will at its session in September 2015 decide on whether to convene a diplomatic conference for the adoption of a Design Law Treaty as soon as practicable."

Categories: Front page

WIPO General Assembly 2014: Draft decision on item 16 (IGC on genetic resources, traditional knowledge & folklore)

Knowledge Ecology International - Tue, 30/09/2014 - 18:04

On 30 September 2014, the WIPO secretariat handed the following draft decision relating to the WIPO Intergovernmental Committee on Intellectual Property and Genetic Resources, Traditional Knowledge and Folklore (IGC).

GA 2014

Draft decision on item 16

The WIPO General Assembly:

(1)) took note of the information contained in document WO/GA/46/6;

(2) took note of the statements made by delegations at the Forty-Sixth Session of the WIPO General Assembly in 2014; and

read more

Categories: Front page

WIPO General Assembly 2014: No Decision Reached on the Work of the Standing Committee on Copyright and Related Rights (SCCR)

Knowledge Ecology International - Tue, 30/09/2014 - 17:53

On Tuesday, 30 September 2014, the Secretariat handed out the following text:

Matters relating to the Standing Committee on Copyright and Related Rights (SCCR) Agenda item 15 Decision Paragraph

The WIPO General Assembly

(i) took note of the information contained in document WO/GA/46/5; and

(ii) took note of the statements made by delegations at the 46th session of the WIPO General Assembly in 2014.

read more

Categories: Front page

European Medicines Agency (EMA) recommends approval of Harvoni, Gilead's all oral HCV combination product

Knowledge Ecology International - Fri, 26/09/2014 - 14:37

The European Medicines Agency (EMA) is recommending approval of Harvoni, a combination of 9mg of ledipasvir (LDV) and 400mg of sofosbuvir (SOF), for the treatment of chronic hepatitis C virus (HCV) infection in adults. This is the "all oral" combination product, delivered in daily does of just 490 mg of API, for the "cure of patients with chronic HCV infection without the need for treatments involving interferons."

read more

Categories: Front page

House Judiciary Committee hearing on trade secret legislation, and the revolving door

Knowledge Ecology International - Thu, 25/09/2014 - 15:45

On September 17, the House Judiciary marked up H.R. 5233, “The Trade Secret Protection Act of 2014.” The bill would create a civil right on action in federal courts for misappropriation of trade secrets, as defined in the bill. [Link to hearing, bill and transcript of markup].

read more

Categories: Front page

WIPO General Assembly 2014: KEI Statement on the Standing Committee on the Law of Patents

Knowledge Ecology International - Thu, 25/09/2014 - 10:26

On Thursday, 25 September 2014, Knowledge Ecology International (KEI) delivered this statement on agenda item 17(i), Reports on other WIPO Committees, (i) Standing on the Law of Patents (SCP).

WIPO General Assembly 2014

17. Reports on other WIPO Committees
(i) Standing Committee on the Law of Patents (SCP);

Statement of Knowledge Ecology International

read more

Categories: Front page

WIPO General Assembly 2014: South Africa Intervention on the Standing Committee on the Law of Patents (SCP)

Knowledge Ecology International - Thu, 25/09/2014 - 09:36

On Thursday, 25 September 2014, South Africa delivered the following intervention on agenda item 17(i) on the Report of the Standing Committee on the Law of Patents (SCP) at the Fifty-Fourth Series of Meetings of the Assemblies of the Member States of WIPO.

South Africa Intervention on the Standing Committee on the Law of Patents (SCP)

read more

Categories: Front page

WIPO General Assembly 2014: KEI statement on Matters Relating to the Standing Committee on Copyright and Related Rights (SCCR)

Knowledge Ecology International - Wed, 24/09/2014 - 15:51

On Wednesday, 24 September 2014, Knowledge Ecology International delivered this intervention on agenda item 15, Matters Relating to the Standing Committee on Copyright and Related Rights (SCCR)

WIPO General Assembly 2014

15. Matters Relating to the Standing Committee on Copyright and Related Rights (SCCR)

Statement of Knowledge Ecology International

read more

Categories: Front page

WIPO General Assembly 2014: KEI statement on the Report of the Committee on Development and Intellectual Property (CDIP)

Knowledge Ecology International - Wed, 24/09/2014 - 15:10

On Wednesday, 24 September 2014, Knowledge Ecology International delivered the following statement at the 2014 WIPO General Assembly on agenda item 13, Report of the Committee on Development and Intellectual Property (CDIP) and Review of the Implementation of the Development Agenda Recommendations.

13. Report of the Committee on Development and Intellectual Property (CDIP) and Review of the Implementation of the Development Agenda Recommendations

Statement of Knowledge Ecology International

read more

Categories: Front page

Comments of KEI regarding the White House OSTP call for comments on its Strategy for American Innovation

Knowledge Ecology International - Wed, 24/09/2014 - 04:19

Comments of KEI regarding the White House OSTP call for comments on its Strategy for American Innovation

(PDF of comments here)

Attn: Dan Correa, Office of Science and Technology Policy, Eisenhower Executive Office Building, 1650 Pennsylvania Ave NW., Washington, DC 20504.
Email: innovationstrategy@ostp.gov.
Re: Strategy for American Innovation
Date: September 23, 2014

read more

Categories: Front page